EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

Mingjie Zou, Haiyuan Zhou iD, Letian Gu, Jingzi Zhang, Lei Fang

Biology · 23.07.2024 · 13 (8) · 555

DOI: 10.3390/biology13080555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 23.07.2024. Verfasst von Mingjie Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Medical School of Nanjing University, Nanjing 2100…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Throughout the human lifespan, from conception to the end of life, small molecules have an intrinsic relationship with numerous physiological processes. The investigation into small-molecule targets holds significant implications for pharmacological discovery. The determination of the action sites of small molecules provide clarity into the pharmacodynamics and toxicological mechanisms of small-molecule drugs, assisting in the elucidation of drug off-target effects and resistance mechanisms. Consequently, innovative methods to study small-molecule targets have proliferated in recent years, with chemical proteomics standing out as a vanguard development in chemical biology in the post-genomic age. Chemical proteomics can non-selectively identify unknown targets of compounds within complex biological matrices, with both probe and non-probe modalities enabling effective target identification. This review attempts to summarize methods and illustrative examples of small-molecule target identification via chemical proteomics. It delves deeply into the interactions between small molecules and human biology to provide pivotal directions and strategies for the discovery and comprehension of novel pharmaceuticals, as well as to improve the evaluation of drug safety.

Schlagwörter

Stichwörter der Autor:innen

chemical proteomicsdrug discoveryoff-targetsmall moleculetarget identification

Autor:innen und Institutionen

  • State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Medical School of Nanjing University, Nanjing 210093, China.

ORCID-Profile: Haiyuan Zhou

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Zou, M., Zhou, H., Gu, L., Zhang, J., & Fang, L. (2024). Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics. Biology, 13(8), 555. https://doi.org/10.3390/biology13080555

Vancouver

Zou M, Zhou H, Gu L, Zhang J, Fang L. Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics. Biology. 2024;13(8):555. doi:10.3390/biology13080555

BibTeX
@article{Zou2024,
  author = {Zou, Mingjie and Zhou, Haiyuan and Gu, Letian and Zhang, Jingzi and Fang, Lei},
  title = {Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics},
  journal = {Biology},
  year = {2024},
  volume = {13},
  number = {8},
  pages = {555},
  doi = {10.3390/biology13080555}
}
Kostenlos starten →